Proteomic analysis of amniotic fluid for the diagnosis of fetal aneuploidies

Expert Review of Proteomics

Volumn 8, Issue 2, 2011, Pages 175-185

  Kolialexi, Aggeliki ^a   Tounta, Georgia ^a   Mavrou, Ariadni ^a   Tsangaris, George Th ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

amniotic fluid; Down syndrome; gestation; Klinefelter syndrome; pregnancy; proteomics; Turner syndrome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; INHIBIN A; PROTEOME;

AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; ANEUPLOIDY; CHROMOSOME ABERRATION; DOWN SYNDROME; EARLY DIAGNOSIS; GESTATIONAL AGE; HIGH THROUGHPUT SCREENING; HUMAN; KLINEFELTER SYNDROME; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PREGNANCY; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; REVIEW; TURNER SYNDROME;

AMNIOTIC FLUID; ANEUPLOIDY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FETUS; HUMANS; PREGNANCY; PROTEOMICS;

EID: 79955052191     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.10.112     Document Type: Review

References (41)

1. Brace RA. Amniotic fluid dynamics. In:Maternal-Fetal Medicine: Principles and Practice. Creasy RK, Resnik R (Ed.). Saunders, PA, USA, 45-53 (2004).
2. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition - a review. Placenta 24(Suppl. A), 33-46 (2003).
3. Brewis IA. Proteomics in reproductive research: the potential importance of proteomics to research in reproduction. Hum. Reprod. 14(12), 2927-2929 (1999).
4. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction 123(4), 487-495 (2002). (Pubitemid 34303150)
5. Jauniaux E, Greenwold N, Hempstock J, Burton GJ. Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil. Steril. 79(1), 100-106 (2003). (Pubitemid 36071246)
6. Mange A, Desmetz C, Bellet V, Molinari N, Maudelonde T, Solassol J. Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids. Proteome Sci. 6, 1 (2008).
7. Wang TH, Chao AS, Chen JK et al. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil. Steril. 92(1), 96-107 (2009).
8. Choolani M, Narasimhan K, Kolla V, Hahn S. Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev. Proteomics 6(1), 87-101 (2009).
9. Brace RA. Physiology of amniotic fluid volume regulation. Clin. Obstet. Gynecol. 40(2), 280-289 (1997). (Pubitemid 27348930)
10. Sohaey R. Amniotic fluid and the umbilical cord: the fetal milieu and lifeline. Semin. Ultrasound CT MR 19(4), 355-369 (1998). (Pubitemid 28378008)
11. Sherer DM. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios. Am. J. Perinatol. 19(5), 253-266 (2002). (Pubitemid 34847566)
12. Orczyk-Pawilowicz M, Florianski J, Zalewski J, Katnik-Prastowska I. Relative amounts of sialic acid and fucose of amniotic fluid glycoconjugates in relation to pregnancy age. Glycoconj. J. 22(7-9), 433-442 (2005). (Pubitemid 41719971)
13. Yeung WS, Lee KF, Koistinen R et al. Roles of glycodelin in modulating sperm function. Mol. Cell Endocrinol. 250(1-2), 149-156 (2006).
14. Irving-Rodgers HF, Roger J, Luck MR, Rodgers RJ. Extracellular matrix of the corpus luteum. Semin. Reprod. Med. 24(4), 242-250 (2006). (Pubitemid 44387528)
15. Malek A, Sager R, Schneider H. Transport of proteins across the human placenta. Am. J. Reprod. Immunol. 40(5), 347-351 (1998). (Pubitemid 28552454)
16. Crettaz D, Thadikkaran L, Gallot D et al. Proteomics of amniotic fluid. In:Proteomics of Human Body Fluids: Principles, Methods, and Applications . Thongboonkerd V (Ed.). Humana Press, NY, USA, 415-436 (2007).
17. Nilsson S, Ramstrom M, Palmblad M, Axelsson O, Bergquist J. Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 3(4), 884-889 (2004). (Pubitemid 39166252)
18. Michel PE, Crettaz D, Morier P et al. Proteome analysis of human plasma and amniotic fluid by off-gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 27(5-6), 1169-1181 (2006).
19. Nagalla SR, Canick JA, Jacob T et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J. Proteome Res. 6(4), 1245-1257 (2007). (Pubitemid 46724021)
20. Shaw JL, Smith CR, Diamandis EP. Proteomic analysis of human cervico-vaginal fluid. J. Proteome Res. 6(7), 2859-2865 (2007). (Pubitemid 47122380)
21. Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol. Cell Proteomics 6(8), 1406-1415 (2007). (Pubitemid 47365438)
22. Chen EI, Hewel J, Felding-Habermann B, Yates JR 3rd. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol. Cell Proteomics 5(1), 53-56 (2006). (Pubitemid 43169340)
23. Irar S, Brini F, Goday A, Masmoudi K, Pages M. Proteomic analysis of wheat embryos with 2-DE and liquid-phase chromatography (ProteomeLab PF-2D) - a wider perspective of the proteome. J. Proteomics 73(9), 1707-1721 (2010).
24. McDonald T, Sheng S, Stanley B et al. Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol. Cell Proteomics 5(12), 2392-2411 (2006). (Pubitemid 46040643)
25. Schlautman JD, Rozek W, Stetler R, Mosley RL, Gendelman HE, Ciborowski P. Multidimensional protein fractionation using ProteomeLab PF 2D for profiling amyotrophic lateral sclerosis immunity: a preliminary report. Proteome Sci. 6, 26 (2008).
26. Wang TH, Chang YL, Peng HH et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat. Diagn. 25(7), 559-566 (2005).
27. Gravett MG, Novy MJ, Rosenfeld RG et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 292(4), 462-469 (2004). (Pubitemid 38988955)
28. Liberatori S, Bini L, De Felice C et al. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 18(15), 2816-2822 (1997). (Pubitemid 28059954)
29. Tsangaris GT, Kolialexi A, Karamessinis PM et al. The normal human amniotic fluid supernatant proteome. In Vivo 20(4), 479-490 (2006). (Pubitemid 44184104)
30. Queloz PA, Crettaz D, Thadikkaran L et al. Proteomic analyses of amniotic fluid: potential applications in health and diseases. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 850(1-2), 336-342 (2007). (Pubitemid 46618180)
31. Michaels JE, Dasari S, Pereira L et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J. Proteome Res. 6(4), 1277-1285 (2007). (Pubitemid 46724024)
32. Tsangaris G, Weitzdorfer R, Pollak D, Lubec G, Fountoulakis M. The amniotic fluid cell proteome. Electrophoresis 26(6), 1168-1173 (2005). (Pubitemid 40514808)
33. Oh JE, Fountoulakis M, Juranville JF, Rosner M, Hengstschlager M, Lubec G. Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics 4(4), 1145-1158 (2004). (Pubitemid 38445972)
34. Tsangaris GT, Karamessinis P, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6(15), 4410-4419 (2006). (Pubitemid 44277042)
35. Mavrou A, Anagnostopoulos AK, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. J. Proteome Res. 7(5), 1862-1866 (2008).
36. Anagnostopoulos AK, Kolialexi A, Mavrou A et al. Proteomic analysis of amniotic fluid in pregnancies with Klinefelter syndrome foetuses. J. Proteomics 73(5), 943-950 (2010).
37. Cho CK, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J. Proteome Res. 9(7), 3574-3582 (2010).
38. Park J, Cha DH, Jung JW et al. Comparative proteomic analysis of human amniotic fluid supernatants with Down syndrome using mass spectrometry. J. Microbiol. Biotechnol. 20(6), 959-967 (2010).
39. Wang CN, Chang SD, Peng HH et al. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction. J. Clin. Endocrinol. Metab. 95(3), 1431-1441 (2010).
40. Malone FD, Canick JA, Ball RH et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N. Engl. J. Med. 353(19), 2001-2011 (2005). (Pubitemid 41609093)
41. Kolialexi A, Tsangaris GT, Papantoniou N et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat. Diagn. 28(8), 691-698 (2008).